-+ 0.00%
-+ 0.00%
-+ 0.00%

New to The Street Show #710 Airs Tonight at 6:30 PM EST on Bloomberg Television

Barchart·12/27/2025 11:00:00
语音播报

Sponsored programming featuring commercials from Synergy CHC (NASDAQ:SNYR), HelloAxel.com (private), The Sustainable Green Team (OTC:SGTM - Waterless Garden), DataVault AI (NASDAQ:DVLT), and PetVivo (OTCQX:PETV).

NEW YORK CITY, NEW YORK / ACCESS Newswire / December 27, 2025 / New to The Street, the long-running global business and financial television platform known for spotlighting category-defining innovators across Web3, biotechnology, artificial intelligence, and real-world asset infrastructure, will broadcast Show #710 tonight at 6:30 PM Eastern Time on Bloomberg Television.

The episode features senior executives leading transformational initiatives in blockchain tokenization, oncology innovation, AI-driven drug development, and global infrastructure strategy, alongside sponsored commercial placements from publicly traded and growth-stage companies.

Featured Executive Interviews

  • Pedro Vidal, Chief Revenue Officer, TokenFI (TOKEN) / Floki (FLOKI)
    Discussion on accelerating institutional adoption of tokenization and the buildout of scalable, compliance-ready infrastructure for real-world asset issuance.

  • Amir Heshmatpour, Chief Executive Officer, NeOnc Technologies (NASDAQ:NTHI)
    Insights into NeOnc's intranasal drug-delivery platform targeting aggressive brain cancers and the company's clinical and regulatory roadmap.

  • Panna Sharma, Chief Executive Officer, Lantern Pharma (NASDAQ:LTRN)
    Overview of Lantern Pharma's AI-driven approach to oncology drug discovery, improving speed, capital efficiency, and probability of clinical success.

  • Monika Proffitt and Douglas Anderson, Co-Chairmen, Mataterra Holdings (private)
    Strategic perspective on global infrastructure development, capital formation, and real-world asset tokenization.

Episode Focus Areas

  • Tokenization as next-generation institutional financial infrastructure

  • AI-enabled acceleration of oncology drug development

  • Breakthrough therapeutic platforms addressing high-unmet medical needs

  • Infrastructure investment and real-world asset digitization

About New to The Street

New to The Street is a nationally broadcast business television series profiling public companies, emerging growth platforms, and market-moving innovation. Now in its 17th year and airing Show #710, the program delivers executive-level storytelling to a global audience through Bloomberg Television, digital syndication, and the New to The Street TV YouTube channel with over 4.2 million subscribers.

Media Contact:
Monica Brennan
Monica@NewtoTheStreet.com

SOURCE: New to The Street



View the original press release on ACCESS Newswire

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.